Drug intelligence / Profile preview

bazedoxifene + conjugated estrogens

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Bazedoxifene + conjugated estrogens is a fixed-dose combination oral medication used in postmenopausal women with an intact uterus to treat moderate to severe vasomotor symptoms (such as hot flashes) and to prevent postmenopausal osteoporosis. Bazedoxifene is a selective estrogen receptor modulator (SERM) that acts as an antagonist in uterine tissue, reducing the risk of endometrial hyperplasia associated with estrogen therapy. Conjugated estrogens are a mixture of naturally occurring estrogen hormones that act as agonists at estrogen receptors, alleviating menopausal symptoms and helping maintain bone density. The combination provides the benefits of hormone replacement while minimizing the need for progestins and reducing certain risks associated with unopposed estrogen therapy[1][3][4][5][8].

Brand names
DuaveeDuavive
Other names
bazedoxifene/conjugated estrogensconjugated estrogens/bazedoxifene
02

Targets

SIGMAR1 (Sigma non-opioid intracellular receptor 1)ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on bazedoxifene + conjugated estrogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bazedoxifene + conjugated estrogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call